Health Care & Life Sciences » Biotechnology | OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals Inc.

OncoMed Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
38.5 M
Public Float
28.42 M
OncoMed Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.28
Market Cap
$103.96 M
Shares Outstanding
38.5 M
Public Float
25.73 M

Profile

Address
800 Chesapeake Drive
Redwood City California 94063
United States
Employees -
Website http://www.oncomed.com
Updated 09/14/2018
OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.

Financials

View All

Perry A. Karsen
Executive Chairman
John A. Lewicki
President, Chief Executive Officer & Director